Recurrent nephrolithiasis — metabolic work-up and prevention
stone prevention · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured evaluation and prevention for recurrent or high-risk kidney stone formers, driven by stone composition and a 24-hour urine metabolic profile. High fluid intake and targeted dietary/pharmacological measures markedly reduce recurrence.
Red flags
- Stones with fever/sepsis (infected obstruction) — emergency
- Bilateral obstruction or solitary kidney obstruction
- Nephrocalcinosis or rapidly growing staghorn stone
- Hypercalcaemia (consider primary hyperparathyroidism)
- Rapidly recurrent stones in a child or young adult
Assessment
Differential diagnosis
- Calcium oxalate stones
- Calcium phosphate stones
- Uric acid stones
- Struvite (infection) stones
- Cystine stones
- Secondary causes (primary hyperparathyroidism, distal RTA, enteric hyperoxaluria)
Investigations
- Stone analysis (composition) — the most informative test
- Two 24-hour urine collections (volume, calcium, oxalate, citrate, uric acid, sodium, pH, cystine)
- Serum calcium, phosphate, PTH, bicarbonate, urate, creatinine
- Urinalysis and urine culture (pH, infection)
- Non-contrast CT KUB to assess stone burden
- Fasting urine pH and morning pH profile (RTA/uric acid clues)
Management
- Identify high-risk/recurrent formers warranting full metabolic evaluation (multiple stones, young age, solitary kidney, non-calcium stones, family history)
- Analyse the stone to direct therapy
- Collect at least one (ideally two) 24-hour urine samples on the patient's usual diet
- Screen for secondary causes: hyperparathyroidism (high Ca/PTH), distal RTA (high urine pH, low citrate), enteric hyperoxaluria
- Advise fluid intake to achieve urine output >2.5 L/day as the universal first step
- Reduce dietary sodium (<2 g/day) and animal protein; maintain normal dietary calcium (do not restrict)
- For hypercalciuria add a thiazide diuretic to lower urinary calcium
- For low citrate or uric acid/cystine stones give potassium citrate to alkalinise urine and raise citrate
- For uric acid stones alkalinise urine to pH 6.5-7 and add allopurinol if hyperuricosuria/hyperuricaemia
- For hyperoxaluria reduce oxalate intake, ensure calcium with meals; treat enteric cause
- Treat struvite stones with complete stone removal plus infection control
- Repeat 24-hour urine at 3-6 months to confirm metabolic response and adjust therapy
Drugs & doses
Potassium citrate 10-20 mEq PO two to three times daily (hypocitraturia, uric acid/cystine stones)
Hydrochlorothiazide 25 mg PO daily OR indapamide 2.5 mg PO daily (hypercalciuria)
Allopurinol 100-300 mg PO daily (uric acid stones / hyperuricosuria)
Tiopronin 100-300 mg PO three times daily (cystine stones, if citrate insufficient)
Pyridoxine 100-300 mg PO daily (selected primary hyperoxaluria)
Disposition
Outpatient stone/metabolic clinic with urology and dietitian input. Urology/emergency referral for obstructing or infected stones.
Complications & pitfalls
- Obstructive uropathy and AKI
- Recurrent urosepsis
- Progressive CKD from recurrent obstruction/nephrocalcinosis
- Staghorn calculi and kidney loss
- Medication side effects (hypokalaemia with thiazide, GI with citrate)
Exam pearls
- Stone composition analysis is the single most useful investigation
- Do NOT restrict dietary calcium — normal calcium with meals binds oxalate
- Target urine output >2.5 L/day — the cheapest effective intervention
- Low urine citrate and low urine pH point to distal RTA
- Thiazides lower urinary calcium; potassium citrate raises citrate and pH
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.